Related Experiment Videos
Adenosine uptake inhibitors.
Tohru Noji1, Akira Karasawa, Hideaki Kusaka
1Pharmaceutical Research Institute, Kyowa Hakko Kogyo Co., Ltd., 1188 Shimotogari, Nagaizumi, Sunto, Shizuoka 411-8731, Japan. tohru.noji@mx6.ttcn.ne.jp
European Journal of Pharmacology
|June 29, 2004
Summary
Adenosine uptake inhibitors can protect against cellular damage by increasing extracellular adenosine levels. These inhibitors show promise for treating various diseases, including ischemia and inflammation.
Area of Science:
- Biochemistry
- Pharmacology
- Physiology
Background:
- Adenosine, a purine nucleoside, regulates physiological functions via cell-surface receptors.
- Extracellular adenosine levels rise during adverse conditions like ischemia and inflammation.
- Elevated adenosine offers protection against cellular damage and organ dysfunction.
Purpose of the Study:
- To investigate the therapeutic potential of adenosine uptake inhibitors.
- To explore how inhibiting adenosine uptake can enhance adenosine's protective effects.
Main Methods:
- Review of preclinical and clinical studies on adenosine uptake inhibitors.
- Analysis of the mechanism of action for adenosine uptake inhibitors.
Main Results:
- Adenosine uptake inhibitors prolong extracellular adenosine levels by blocking cellular reuptake.
- Reported protective effects include amelioration of ischemic injury, seizures, and inflammation.
- Evidence suggests efficacy in conditions like organ transplantation, thrombosis, pain, and insomnia.
Conclusions:
- Adenosine uptake inhibitors represent a promising therapeutic strategy.
- Elevating extracellular adenosine through uptake inhibition offers broad protective benefits.
- Further clinical application of these inhibitors is indicated.